The first protein component of the Escherichia coli phosphoenolpyruvate:sugar phosphotransferase system (PTS) is the 64-kDa protein enzyme I (El), which can be phosphorylated by phosphoenolpyruvate (PEP) 
The phosphoenolpyruvate:sugar phosphotransferase system (PTS) (1) is widespread in bacteria and plays an important role in the translocation from the medium of a variety of sugar substrates. In the case of glucose transport in Escherichia coli, there are three soluble PTS components [enzyme I (El) , the heat-stable protein (HPr), and enzyme IIAgIc (EIIAs1c)]. While the solution and crystal structures of several species of HPr and EIlAgic have been solved, that of El has not. The 64-kDa size of El eliminates it from consideration for structure studies by NMR. Further, the poor quality of crystals of El has not allowed analysis by x-ray diffraction. Thermodynamic (2) and proteolytic (3) studies of El have led to a model structure that is composed of two domains; the amino-terminal domain, EIN, containing the active site, is well ordered, and the carboxylterminal domain is relatively flexible. El functions by accepting a phosphate group from phosphoenolpyruvate (PEP) (at His-189) and then transferring it to HPr (at His-15). While EIN is incapable of becoming phosphorylated by PEP, it retains the capacity to be reversibly phosphorylated by HPr. With the intention of exploring the possibility that EIN might be a more successful candidate for structure studies and to define structure-function aspects of the amino-terminal domain, a vector was designed to overexpress EIN. Large quantities of the protein have been purified in good yield and aspects of the phosphotransfer reactions of El and EIN have been defined.
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MATERIALS AND METHODS
The self-complementary oligonucleotide 5'-GATCGGTGAT-AGGATCCGGATCCTATCACC-3' was synthesized by using a model 394 DNA/RNA synthesizer (Applied Biosystems). Restriction endonucleases and T4 DNA ligase were purchased from New England Biolabs. Tryptophan was purchased from Bethesda Research Laboratories. DE-52 DEAE-cellulose was obtained from Whatman. Ultrogel AcA 44 was purchased from IBF Biotechnics (Savage, MD). [y-32P]ATP was purchased from DuPont. E. coli El (4), HPr (4), and EllAgic (4) and Mycobacterium capricolum HPr (5) were prepared as previously described. The gene encoding M. capricolum EllAgic (6) was cloned in the expression vector pREI (4). Expression and purification of the protein, to be described elsewhere, used a strategy similar to that for the purification of HPr from M. capricolum (5). Bacillus subtilis HPr was a gift from Jonathan Reizer (University of California, San Diego). Protein concentration was determined by the spectrophotometric method of Waddell (7) or by staining with Bio-Rad Coomassie blue solution, following the supplier's instructions and using bovine serum albumin as a standard. SDS/PAGE was carried out according to Laemmli (8) . Densities of proteins in stained gels and autoradiograms were quantified by using the NIH IMAGE program (version 1.55) developed at the National Institutes of Health by Wayne Rasband.
E. coli strain GI698 contains a single copy of the A cI gene, encoding the A repressor, stably integrated into the chromosomal ampC locus (9). The cI gene is under the transcriptional control of the trp promoter. This strain was grown at 30°C in synthetic medium containing 1 x M9 salts, 2% Bacto-casamino acids (Difco), 1% glycerol, 1 mM MgCl2, and 0.1 mM CaCl2. pLP2, prepared as described in the legend to Fig. 1 This is the region previously shown (3) to separate the amino-terminal from the carboxyl-terminal domains of El. pPR6 was linearized by treatment with Bgl II to interrupt the coding sequence of ptsI between the two domains. A synthetic palindromic linker with 5' overhangs compatible with Bgl II was ligated to the linearized pPR6. The characteristic feature of the linker was that it placed after codon 258 an arginine codon followed by two stop codons (Fig. 1B) . For the purpose of screening for successful constructs, the linker also contained a pair of BamHI sites. It was anticipated that pLP2 would allow the overexpression of a truncated version of El containing only the amino-terminal domain.
E. coli G1698 transformed with the pLP2 recombinant plasmid was used for the overproduction of the amino-terminal domain of El. In this strain, the A cI repressor gene is under the control of the trp promoter, which is repressed by tryptophan (9). Tryptophan (0.1 mg/ml) was added to a midlogarithmic-phase culture to induce the expression of the protein. Crude extracts of cells were analyzed by SDS/PAGE as a function of induction time (Fig. 2) . Analysis of the Coomassie blue-stained gel with NIH IMAGE showed that EIN was overproduced to about 30% of the total cell protein in 16-28 hr after induction.
EIN was purified from a culture grown as described in the legend to Fig. 2 and induced for 20 hr (see Fig. 3 ). From 500 ml of culture, 3.5 g (wet weight) of induced cells was obtained. The washed cells were suspended in 20 ml of 10 mM Tris HCl at pH 7.5 (buffer A) containing 100 mM NaCl and ruptured by two passages through a French pressure cell at 10,000 psi (6.9 MPa). The cell-free extract was centrifuged at 100,000 x g for 90 min, and the supernatant fraction was loaded onto a DE-52 anion-exchange column (2.5 x 25 cm) equilibrated with buffer A containing 100 mM NaCl. (Fig. 3, lane 6 ). The sample was applied to the column equilibrated with buffer A containing 100 mM NaCl, the column was washed with 20 ml of buffer A containing 100 mM NaCl, and EIN was eluted with a linear salt gradient (100 ml volume, from buffer A containing 100 mM NaCl to buffer A containing 400 mM NaCl). The results of the experiments shown in Fig. 4 establish that the tight specificity with respect to phosphotransfer to a variety of acceptors characteristic of P-El is considerably relaxed when P-EIN is used as a phosphoryl donor. This strongly suggests that the carboxyl-terminal domain of EI is an important determinant for phosphoryl acceptor specificity.
DISCUSSION
The results of the studies presented here show that, with the expression vector described here, EIN can be stably expressed in E. coli. It has been possible to prepare 80 mg of homogeneous material from a relatively small (500-ml) culture. A major incentive for devising a method for preparing pure preparations of EIN was to overcome the problems experienced with poor crystallization success with El. Recent studies in the laboratory of D. Davies have shown that EIN forms crystals that diffract well (D. Liao, E. Silverton, and D. Davies, personal communication). Consequently, the solution of the structure of the amino-terminal domain of El is underway and will be reported elsewhere.
The structures of five species of HPr (13, 14) have been solved, and they are all quite similar, showing an open-face 13-sandwich folding topology. However, several studies have demonstrated that P-El from a particular bacterial species carries out phosphoryl transfer poorly or not at all to an HPr from another species (6, 12, 15, 16). Since P-EIN retains the capability of catalyzing the reversible phosphoryl transfer to HPr, we studied the ability of the amino-terminal domain of El to discriminate among HPrs from a variety of species. Fig. 5 shows the sequences of the Els from B. subtilis, M. capricolum, and E. coli (6). For the purposes of comparison, B. subtilis M. capricolum E. coli the residues that are identical are shown highlighted in reverse shading and those that are similar are shaded in grey. From this sequence alignment, it appears that the amino-terminal domains (approximately the first 250 residues) differ considerably more than do the carboxyl-terminal domains. It therefore seemed reasonable to predict that the capabilities of Els to discriminate among various HPr species are likely to be encoded in the amino-terminal domains. The surprising finding, shown in Fig. 4 , was that P-EIN is incapable of discriminating among HPrs as phospho-acceptors.
EIN shows additional phospho-donor specificity changes compared with El. While the phosphotransfer from P-El to EIN can proceed via HPr, that from P-EIN to El is possible in the absence of HPr. Similarly, phosphotransfer from P-EL to E.
coli EllAgic requires the intermediacy of HPr, but P-EIN phosphorylates E. coli EllAgIc directly. The phospho-acceptor specificities of El and EIN elucidated in this work are shown schematically in Fig. 6 of HPr from the preparation of P-EIN used in the study shown in Fig. 4 . This is considered unlikely for two reasons. First, as shown in Fig. 4D , lanes 8 and 9, there was no phosphoryl transfer from P-EIN to M. capricolum EllAgIc unless the reaction mixture was supplemented with HPr (lane 9). Second, the preparation of P-EIN used in the study of Fig. 4 was tested immunologically for the presence of HPr. Samples of P-EIN
(1-5 jig) showed no indication for the presence of HPr in a Western blot capable of detecting 20 ng of E. coli HPr (data not shown).
The observed loosening of specificity for phosphotransfer associated with EIN led to questioning whether P-EIN was a general phosphoryl donor. This was clearly not the case since, while P-EIN will catalyze phosphotransfer to E. coli ElIAgic, it will not directly phosphorylate the EllAgIc from M. capricolum (Fig. 4) . Furthermore, P-EIN will not phosphorylate pyruvate (as does P-EI), histidine, or the peptide pyroglutamylhistidylprolineamide (thyrotropin-releasing hormone) (data not shown).
The specificity studies presented here and those presented previously (6, 12, 15, 16) 
